Clinical outcome of cardiac surgery in patients with remitted or active hepatocellular carcinoma.
Kazuyoshi TakagiKoichi ArinagaTohru TakaseyaHiroyuki OtsukaTakahiro ShojimaYusuke ShintaniTakanori KonoYasuyuki ZaimaSatoshi KikusakiKosuke SakuAtsunobu OryojiEiki TayamaPublished in: Surgery today (2021)
We could safely perform cardiac surgery in selected patients with remitted and active HCC. The postoperative life expectancy of these patients was limited but acceptable.